https://youtu.be/n1I8sIB-qug
EOFlow, South Korea: Stop selling instruments in Germany!
– ‘GlucoMen Day PUMP’ granted preliminary injunction in patent lawsuit –
Korea・EOFlow:
EOFlow faces medical device sales ban in Germany.
EOFlow seems to have suspended “GlucoMen Day PUMP sales in Germany”.
GlucoMen Day PUMP is a blood sugar control device.
Insulator:
-Insulet is Germany’s No. 1 insulin pump company-
Filed a “provisional injunction relating to patents in Germany” and suspended product sales in Germany.
It remains to be seen “whether the suspension will be extended to other European markets”.
According to industry sources on March 24, the Düsseldorf Court
recently granted a preliminary injunction against Menarini’s German subsidiary, Berlin Chemie, to suspend sales of the GlucoMen Day PUMP.
The product was developed by Korean insulin pump developer EOFlow.
EOFlow signed a five-year, 150 billion won (US$150 million) contract with Menarini in late 2021 to exclusively supply the wearable insulin pump EOPatch.
However, just six months since the GlucoMen Day PUMP’s launch,
it was taken of German shelves
as the German court accepted the preliminary injunction against the sale of the insulin pump’s fluid supply device patent filed by rival company Insulet.Previously,
Insulet filed a similar patent dispute against Metrum Group,which entered the German market earlier, over a patent related to the technology.
It is reportedly in the process of appealing to the Düsseldorf Higher Regional Court.
– Businesskorea
http://www.businesskorea.co.kr/news/articleView.html?idxno=111691
Insulet and Peterreins Schley win PI over insulin pumps at Düsseldorf Regional Court
Italian company Menarini Diagnostics
may no longer sell its insulin pump GlucoMen Day Pump through Berlin Chemie, which is its subsidiary in Germany.
Insulet recently enforced an injunction handed down by Düsseldorf Regional Court.
However, this is certainly not the end of the dispute between the two medical device manufacturers.
– JUVE Patent
EOFlow, Corée du Sud : Arrêtez de vendre des instruments en Allemagne !
– ‘GlucoMen Day PUMP’ obtient une injonction préliminaire dans le cadre d’un procès en matière de brevet –
Corée・EOFlow :
EOFlow fait face à une interdiction de vente de dispositifs médicaux en Allemagne.
EOFlow semble avoir suspendu “les ventes de GlucoMen Day PUMP en Allemagne”.
GlucoMen Day PUMP est un dispositif de contrôle de la glycémie.
Isolant:
-Insulet est le numéro 1 des pompes à insuline en Allemagne-
A déposé une “injonction provisoire relative aux brevets en Allemagne” et suspendu les ventes de produits en Allemagne.
Reste à savoir “si la suspension sera étendue à d’autres marchés européens”.
EOFlow, Südkorea: Stoppen Sie den Verkauf von Instrumenten in Deutschland!
– ‘GlucoMen Day PUMP’ erlässt einstweilige Verfügung in Patentklage –
Korea・EOFlow:
EOFlow droht in Deutschland ein Verkaufsverbot für Medizinprodukte.
EOFlow scheint den Verkauf von “GlucoMen Day PUMPs in Deutschland” eingestellt zu haben.
GlucoMen Day PUMP ist ein Blutzuckerkontrollgerät.
Isolator:
-Insulet ist Deutschlands Hersteller von Insulinpumpen Nr. 1-
„Einstweilige Verfügung betreffend Patente in Deutschland“ beantragt und Produktvertrieb in Deutschland eingestellt.
Es bleibe abzuwarten, „ob die Aussetzung auf weitere europäische Märkte ausgeweitet wird“.